Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies

NCT02006485

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States
  • TG Therapeutics Investigational Trial Site Duarte, California, United States
  • TG Therapeutics Investigational Trial Site Atlanta, Georgia, United States
View Trial Details
Completed

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

NCT00106431

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • UCLA Jonsson Cancer Center Los Angeles, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • University of Pennsylvania Abrahamson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00105001

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
View Trial Details
Completed

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

NCT03357471

Conditions
Active Ankylosing Spondylitis, Active Psoriatic Arthritis, Hemic and Lymphatic Diseases, +11 more
Locations
  • Ra0098 116 Mesa, Arizona, United States
  • Ra0098 107 Mesa, Arizona, United States
  • Ra0098 135 Phoenix, Arizona, United States
  • Ra0098 119 Tucson, Arizona, United States
View all 22 locations
View Trial Details
Completed

Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

NCT01076543

Conditions
AIDS-Related Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +27 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View Trial Details
Completed

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma

NCT01980628

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Site Reference ID/Investigator# 837 Tucson, Arizona, United States
  • Site Reference ID/Investigator# 047 Duarte, California, United States
  • Site Reference ID/Investigator# 377 Santa Monica, California, United States
  • Site Reference ID/Investigator# 763 West Palm Beach, Florida, United States
View all 25 locations
View Trial Details

Related conditions